Hikaru Murakami

Osaka University of Pharmaceutical Sciences

Papers

1

Total Citations

2

H-Index

1

About

Dr. Hikaru Murakami is a leading gynecologic oncologist whose research focuses on refining surgical approaches for early-stage cervical cancer, particularly through the integration of sentinel lymph node biopsy (SNB). His most cited work, "Oncologic Outcomes of Patients with Early-Stage Cervical Cancer after Minimally Invasive Radical Hysterectomy and Sentinel Lymph Node Biopsy" (2024), addresses a critical gap in the literature by comparing oncological outcomes in patients undergoing SNB versus standard lymphadenectomy. This study provides foundational evidence that SNB may offer comparable safety while reducing surgical morbidity, potentially shifting clinical practice toward more targeted, less invasive staging. Dr. Murakami’s contributions are especially timely given ongoing debates about the role of minimally invasive surgery in cervical cancer. Though his work is early in its citation trajectory, its clinical relevance positions him as an emerging authority in precision surgical oncology. His research bridges the gap between technical innovation and patient-centered outcomes, offering a roadmap for future trials that could redefine standards of care for early-stage cervical cancer worldwide.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
Oncologic Outcomes of Patients with Early-Stage Cervical Cancer after Minimally Invasive Radical Hysterectomy and Sentinel Lymph Node Biopsy
2 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 12
🏛 Institutions: Osaka University of Pharmaceutical Sciences

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago